Enrollment Timeline Reduced by 43%
Case Study
Mar 20, 2020
Unique predictive enrollment model reduced projected enrollment period from 52 to 30 weeks
A leading pharmaceutical company with a focus on men and women’s health selected the IQVIA Biotech dermatology team to provide patient recruitment services for a Phase III external genital warts study. With a proven patient recruitment process and a record of successfully enrolled clinical studies, IQVIA Biotech was poised to save the sponsor time and mpney. Unique predictive enrollment model reduced projected enrollment period from 52 to 30 weeks.